Pacific RxTracts - March 2025

Authors

Pacific RxTracts

Files

Description

Articles

• Naloxone Extended-Release System Discovered at the University of the Pacific
• FDA Approval for Unresectable/ Metastatic Breast Cancer
• Journavx (Suzetrigine): A New Era in Pain Management
• New Treatment Approved for Congenital Adrenal Hyperplasia
• Optimal DAPT Strategy? A Promising Approach for Post-PCI Care
• Benefit of SGLT2 Inhibitors in Preventing Contrast-Induced Kidney Injury
• Dark Chocolate and Type 2 Diabetes: A Sweet Connection?
• Confirming Palbociclib’s Safety in Liver Impaired Patients
• Aztreonam-avibactam, a Promising Therapeutic for Gram-Negative Bacterial Infections
• The Future is Now: LBP-EC01, a Genetically Enhanced Bacteriophage for UTIs
• The Safety and Efficacy Profiles of Short-Term Duration Oral Regimens for Rifampin-Resistant TB
• A New Boxed Warning for Glatiramer Acetate
• Clozapine: From Last Resort to Second-Line Therapy?
• Esketamine (Spravato CIII) Receives FDA Approval as First Monotherapy Treatment for Treatment-Resistant Depression
• Evaluation of the Impacts of Cannabis Use on Brain Function

Publication Date

3-3-2025

Volume

22

Issue

5

Pages

5

Publisher

University of the Pacific

City

Stockton, CA

Disciplines

Medicine and Health Sciences | Pharmacy and Pharmaceutical Sciences

Recommended Citation

Pacific RxTracts, "Pacific RxTracts - March 2025" (2025). Pacific RxTracts. 5.
https://scholarlycommons.pacific.edu/rx-tracts/5